IMUN - Immune Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue3.46316.197-
Cost of Revenue---
Gross Profit3.46316.197-
Operating Expenses
Research Development444.165977.2032,413.286
Selling General and Administrative13,829.6299,020.74630,063.178
Non Recurring-5,226.3529,908.477
Others1.557594.7852,879.311
Total Operating Expenses-15,819.08645,264.252
Operating Income or Loss-14,271.888-15,802.889-45,264.252
Income from Continuing Operations
Total Other Income/Expenses Net-2,100.549-875.573-4,285.74
Earnings Before Interest and Taxes-16,372.437-16,678.462-49,549.992
Interest Expense3,446.564270.989388.221
Income Before Tax-19,819.001-16,949.451-49,938.213
Income Tax Expense---
Minority Interest-3,990.366-2,100.452606.487
Net Income From Continuing Ops-19,521.401-14,242.512-48,253.217
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-19,521.401-14,242.512-48,253.217
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-19,521.401-14,242.512-48,253.217